These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1489196)

  • 21. Temperature effects on the aggregation state and activity of amphotericin B.
    Lambing HE; Wolf BD; Hartsel SC
    Biochim Biophys Acta; 1993 Oct; 1152(1):185-8. PubMed ID: 8399298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose.
    Gruda I; Milette D; Brother M; Kobayashi GS; Medoff G; Brajtburg J
    Antimicrob Agents Chemother; 1991 Jan; 35(1):24-8. PubMed ID: 2014979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aggregation state on the toxicity of different amphotericin B preparations.
    Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions.
    Ramos H; Valdivieso E; Gamargo M; Dagger F; Cohen BE
    J Membr Biol; 1996 Jul; 152(1):65-75. PubMed ID: 8660406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes.
    Kagan S; Ickowicz DE; Domb AJ; Dagan A; Polacheck I
    Med Mycol; 2017 Jun; 55(4):414-421. PubMed ID: 28339539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
    Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
    Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity.
    Gurudevan S; Francis AP; Jayakrishnan A
    Eur J Pharm Sci; 2018 Mar; 115():167-174. PubMed ID: 29325755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.
    Cybulska B; Gadomska I; Mazerski J; Borowski JGE ; Cheron M; Bolard J
    Acta Biochim Pol; 2000; 47(1):121-31. PubMed ID: 10961685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular dichroism studies on intermolecular interactions of amphotericin B in ionic liquid-rich environments.
    Jameson LP; Dzyuba SV
    Chirality; 2013 Jul; 25(7):427-32. PubMed ID: 23695916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of diet on experimental toxicity of amphotericin B deoxycholate.
    Chavanet P; Joly V; Rigaud D; Bolard J; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1994 May; 38(5):963-8. PubMed ID: 8067777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The formation of amphotericin B ion channels in lipid bilayers.
    Fujii G; Chang JE; Coley T; Steere B
    Biochemistry; 1997 Apr; 36(16):4959-68. PubMed ID: 9125518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations.
    Das S; Devarajan PV
    Mol Pharm; 2020 Jun; 17(6):2186-2195. PubMed ID: 32324420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.
    Adediran SA; Day TP; Sil D; Kimbrell MR; Warshakoon HJ; Malladi SS; David SA
    Mol Pharm; 2009; 6(5):1582-90. PubMed ID: 19663403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of amphotericin B membrane interaction by cholesterol and ergosterol--a molecular dynamics study.
    Czub J; Baginski M
    J Phys Chem B; 2006 Aug; 110(33):16743-53. PubMed ID: 16913814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic.
    Baginski M; Sternal K; Czub J; Borowski E
    Acta Biochim Pol; 2005; 52(3):655-8. PubMed ID: 16086075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.
    Oda MN; Hargreaves PL; Beckstead JA; Redmond KA; van Antwerpen R; Ryan RO
    J Lipid Res; 2006 Feb; 47(2):260-7. PubMed ID: 16314670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amphotericin B channel conductance inactivation].
    Ibragimova VKh; Alieva IN; Aliev DI
    Tsitologiia; 2003; 45(8):804-11. PubMed ID: 15216632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Dec; 193(1):97-106. PubMed ID: 10581426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.